Rise Advisors’s Amplify Seymour Cannabis ETF CNBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-12
Closed -$203 1570
2025
Q1
$203 Buy
12
+4
+50% +$82 ﹤0.01% 1437
2024
Q4
$205 Hold
8
﹤0.01% 1111
2024
Q3
$449 Hold
8
﹤0.01% 1196
2024
Q2
$447 Hold
8
﹤0.01% 1196
2024
Q1
$577 Hold
8
﹤0.01% 1208
2023
Q4
$427 Hold
8
﹤0.01% 572
2023
Q3
$482 Hold
8
﹤0.01% 583
2023
Q2
$370 Hold
8
﹤0.01% 635
2023
Q1
$421 Hold
8
﹤0.01% 746
2022
Q4
$509 Hold
8
﹤0.01% 710
2022
Q3
$1K Hold
8
﹤0.01% 609
2022
Q2
$1K Hold
8
﹤0.01% 618
2022
Q1
$1K Hold
8
﹤0.01% 587
2021
Q4
$1.41K Buy
+8
New +$1.61K ﹤0.01% 572

Other funds holding CNBS

Rise Advisors's CNBS Position: Q2 2025 in Review

Rise Advisors sold out of Amplify Seymour Cannabis ETF (CNBS) in Q2 2025, closing a stake of 12 shares — an estimated $203 sold.

Rise Advisors first reported a position in CNBS in Q4 2021 and held it in 14 quarters. The position peaked at $1.41K in Q4 2021. 18 funds tracked by Wall St. Rank hold CNBS as of Q2 2025.

  • Rise Advisors reported no remaining Amplify Seymour Cannabis ETF position as of Q2 2025 after selling out during the quarter.
  • Rise Advisors sold 12 Amplify Seymour Cannabis ETF shares in Q2 2025, an estimated $203.
  • Rise Advisors first reported a position in Amplify Seymour Cannabis ETF in Q4 2021 and held it in 14 quarters.
  • Rise Advisors's Amplify Seymour Cannabis ETF position peaked at $1.41K in Q4 2021.
  • 18 funds tracked by Wall St. Rank held Amplify Seymour Cannabis ETF as of Q2 2025.

Based on Rise Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.